China-U.S. Exchange Foundation President James Chau to Speak at One Young World Summit 2024 in Montréal
Inaugural CUSEF x One Young World Scholars will also participate in the annual summit for young leaders that brings together more than 2,000 people from 190+ countries MONTREAL, Sept. 20, 2024 /PRNewswire/ — James Chau, President of the China-United States Exchange Foundation (CUSEF), a non-go
FAU/MAINSTREET USA POLL: HARRIS EDGES TRUMP; BUT DEMOCRACY, TARIFF DOUBTS LINGER
Voters Offer Opinions on Taylor Swift Endorsement and Voting Preferences BOCA RATON, Fla., Sept. 20, 2024 /PRNewswire/ — A new national poll from the Florida Atlantic University Political Communication and Public Opinion Research Lab (PolCom Lab) and Mainstreet Research USA shows U.S. Vice Pre
Global Cancer Rates Surge as Biotech Innovators Work on New Therapies
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Sept. 20, 2024 /PRNewswire/ — USA News Group – Cancer rates are rising globally, and the outlook is particularly concerning for men. A recent global study projects an 84% increase in cancer cases and a 93% rise in cancer deaths amo
Lennox Declares Quarterly Dividend
DALLAS, Sept. 20, 2024 /PRNewswire/ — The Lennox board of directors (NYSE: LII) approved a quarterly cash dividend of $1.15 per share of common stock, payable October 15, 2024, to stockholders of record as of September 30, 2024. About LennoxLennox (NYSE: LII) is a leader in energy-efficient c
Alaska Air Group announces Investor Day in December
Following the acquisition of Hawaiian Airlines, the combined organization will shed light on future plans SEATTLE, Sept. 20, 2024 /PRNewswire/ — Alaska Air Group, Inc. will hold an Investor Day presentation in New York City on Tuesday, Dec. 10, 2024. The event will feature presentations and a
FDA Approves First Treatment for Niemann-Pick Disease, Type C
SILVER SPRING, Md., Sept. 20, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC). Miplyffa, in combination with the enzyme inhibitor miglustat, is approved to treat neurol
Goulston & Storrs Recognized for Banking, M&A, and Restructuring/Insolvency in 2024 IFLR1000
Pamela MacKenzie ranked as a top banking attorney in Massachusetts BOSTON, Sept. 20, 2024 /PRNewswire/ — Goulston & Storrs, an Am Law 200 firm, is pleased to announce that the firm received top rankings in the IFLR1000, a U.S. directory of leading corporate and financial law firms and lawy
Pure Storage Named a Leader in the 2024 Gartner® Magic Quadrant™ for Primary Storage Platforms
Latest recognition marks eleventh consecutive year of Pure Storage being recognized as a Gartner Magic Quadrant Leader SANTA CLARA, Calif., Sept. 20, 2024 /PRNewswire/ — Pure Storage® (NYSE: PSTG), the IT pioneer that delivers the world’s most advanced data storage technology and servi
Autonomous Mobile Robots (AMR) Market to cross $10 Billion TAM with around 500K AMRs shipment by 2030 – LogisticsIQ
NEW DELHI, Sept. 20, 2024 /PRNewswire/ — The global Autonomous Mobile Robots (AMRs) market is poised for significant growth, driven by increasing demand for automation across various sectors, including logistics, manufacturing, and healthcare. According to the latest market research by Logist
Gold Kidney Health Plan Expands in Florida and Arizona in 2025
SCOTTSDALE, Ariz., Sept. 20, 2024 /PRNewswire/ — Gold Kidney Health Plan, a leading Medicare Advantage health plan, is excited to announce its significant expansion in Florida and Arizona for 2025. The company is increasing its footprint from 9 markets to 22 counties in Florida and from 4 to
